Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 26 | 26 |
| 1994 | 0 | 22 | 22 |
| 1995 | 0 | 35 | 35 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 17 | 17 |
| 1998 | 0 | 29 | 29 |
| 1999 | 0 | 31 | 31 |
| 2000 | 0 | 23 | 23 |
| 2001 | 1 | 32 | 33 |
| 2002 | 0 | 24 | 24 |
| 2003 | 0 | 35 | 35 |
| 2004 | 1 | 41 | 42 |
| 2005 | 1 | 30 | 31 |
| 2006 | 1 | 23 | 24 |
| 2007 | 1 | 42 | 43 |
| 2008 | 1 | 48 | 49 |
| 2009 | 1 | 43 | 44 |
| 2010 | 0 | 48 | 48 |
| 2011 | 0 | 39 | 39 |
| 2012 | 0 | 32 | 32 |
| 2013 | 0 | 34 | 34 |
| 2014 | 0 | 30 | 30 |
| 2015 | 1 | 25 | 26 |
| 2016 | 0 | 40 | 40 |
| 2017 | 0 | 38 | 38 |
| 2018 | 1 | 31 | 32 |
| 2019 | 1 | 38 | 39 |
| 2020 | 0 | 31 | 31 |
| 2021 | 0 | 22 | 22 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference. Oncoimmunology. 2023; 12(1):2222560.
-
ASO Visual Abstract: PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence for Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 05; 30(5):3123-3124.
-
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. J Clin Oncol. 2023 06 10; 41(17):3203-3216.
-
Multimodality treatment for recurrent neuroblastoma in the central nervous system. Pediatr Blood Cancer. 2023 04; 70(4):e30227.
-
PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery. Ann Surg Oncol. 2023 May; 30(5):3114-3122.
-
Rational combination therapy for NASH: Insights from clinical trials and error. J Hepatol. 2023 05; 78(5):1073-1079.
-
Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2023 03; 283:1154-1160.
-
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. J Clin Oncol. 2023 03 01; 41(7):1370-1375.
-
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 06; 165(6):1949-1953.
-
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213.